BCR Endpoints an Unreliable Surrogate for Survival in Prostate Cancer Trials

As an early event, biochemical recurrence (BCR) in prostate cancer garnered great interest as a potential surrogate trial endpoint for overall survival.

Related Keywords

California ,United States ,Amaru Kishan ,Los Angeles ,University Of California ,